Legal Representation
Attorney
Emily R. Billig
USPTO Deadlines
Next Deadline
84 days remaining
Final Refusal E-Mailed - 3-Month Extension Granted (XELG on 2026-01-08)
Due Date
April 08, 2026
Extension Available
Until April 08, 2026
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 8, 2026 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jan 8, 2026 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Oct 8, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Oct 8, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Oct 8, 2025 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Sep 24, 2025 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Sep 5, 2025 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Sep 23, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 5, 2025 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Sep 5, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 5, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 5, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 5, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 5, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 5, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 27, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 6, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 6, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Providing information about medical research; providing information about medical research in the field of type 1 diabetes; Providing information about medical and scientific research via a website; Providing medical and scientific research information in the field of clinical trials; Medical and scientific research services, namely, conducting clinical trials for others, namely, developing guidelines for clinical trial models and endpoints
First Use Anywhere:
Nov 14, 2024
First Use in Commerce:
Nov 14, 2024
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PROJECT"